rhGAD65 formulated in Alhydrogel® (Diamyd®)

Phase 2

Phase 2

Development Phase

Upcoming Catalysts

Historical Events

Regulatory Approvals

No catalyst events have been recorded for this drug yet.

Competitive Landscape

0 competitors in Latent Autoimmune Diabetes in Adult (LADA)

Drug Information

Target Indication

Latent Autoimmune Diabetes in Adult (LADA)

Clinical Trial

Last updated: 6/28/2026

Patent & Exclusivity

No patent data available. Pre-approval drugs may not have Orange Book listings.

Drug Science

Mechanism of action & safety profile

Developer

DMYD-B.ST

Diamyd Medical AB

Related Pipeline

Type 1 Diabetes Mellitus

Diabetes Mellitus, Type 1

Intractable Pain

Get Catalyst Alerts

Receive weekly digests of upcoming catalysts